Tender Number 1

This tender, designated as Tender Number 1 (sub-contract), pertains to the procurement of specific pharmaceutical products. The core item detailed is Lamivudine, identified by ATC Code J05AF05. This medication is to be supplied in tablet form, with a strength of 100 mg. The unit value is specified as 0.3 g, and the estimated quantity required is 3932 units. Each tender number is treated as an independent sub-contract, and bids will be evaluated separately for each. Suppliers have the flexibility to submit offers for one, multiple, or all available tender numbers, with contract awards made on an individual basis for each tender number. Consequently, a single supplier may be awarded one, several, or all of the sub-contracts. Interested parties are directed to the tender conditions for comprehensive details on bid submission requirements for each tender number. The "quantity in units" stated above represents an estimated consumption; however, the actual demand may vary significantly. Suppliers must account for this potential fluctuation, as the pharmaceuticals are intended for patient treatment in public hospitals, where patient needs are paramount. Further detailed information regarding the scope of work, specifications, and the framework agreement can be found within the official tender documentation.

This is a supplies contract in the health and medical services and general supplies sectors, with a focus on Pharmaceuticals. Located in Denmark, Europe, this opportunity is open to firms and consortiums, with an estimated budget of DKK 373,211.

Published through TED - Tenders Electronic Daily (EU), a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.